Efficacy of mometasone/indacaterol/glycopyrronium (MF/IND/GLY) on lung function and exacerbations in patients with inadequately controlled asthma with high-dose ICS/LABA therapy (on GINA step 5) prior to study entry: Results from IRIDIUM study

被引：0

作者：

Maspero, Jorge ^{[1
]}

Kerstjens, Huib A. M. ^{[2
,3
]}

Chapman, Kenneth R. ^{[4
]}

Van Zyl-Smit, Richard ^{[5
,6
]}

Tanase, Ana-Maria ^{[7
]}

Lawrence, David ^{[8
]}

Pethe, Abhijit ^{[8
]}

Mezzi, Karen ^{[7
]}

D'Andrea, Peter ^{[8
]}

机构：

[1] Fdn CIDEA, Allergy & Resp Res Unit, Buenos Aires, DF, Argentina

[2] Univ Groningen, Univ Med Ctr Groningen, Dept Pulmonol, Groningen, Netherlands

[3] Groningen Res Inst Asthma & COPD, Groningen, Netherlands

[4] Univ Toronto, Div Resp Med, Dept Med, Toronto, ON, Canada

[5] Univ Cape Town, Div Pulmonol, Cape Town, South Africa

[6] Univ Cape Town, UCT Lung Inst, Cape Town, South Africa

[7] Novartis Pharma AG, Basel, Switzerland

[8] Novartis Pharmaceut, E Hanover, NJ USA

来源：

关键词：

Treatments; Asthma; -; management;

D O I：

10.1183/13993003.congress-2021.PA3391

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

PA3391

引用

页数：3